Finance

Beta
Lists
HEPA:OTCMKTS
Hepion Pharmaceuticals Inc
$0.052
-6.98%
(-0.0039) 1D
Jun 12, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HEPA...
Open
$0.08
High
$0.08
Low
$0.05
Mkt. cap
1.41M
Avg. vol.
26.53K
Volume
12.10K
52-wk high
$0.25
52-wk low
$0.03
EPS
-$0.26
Beta
1.68
Shares outstanding
29.12M
No. of employees
2
Open
$0.08
High
$0.08
Low
$0.05
Mkt. cap
1.41M
Avg. vol.
26.53K
Volume
12.10K
52-wk high
$0.25
52-wk low
$0.03
EPS
-$0.26
Beta
1.68
Shares outstanding
29.12M
No. of employees
2
News stories
From sources across the web
About Hepion Pharmaceuticals Inc
CEO-
Employees2
Founded2013
Headquarters-
SectorPharmaceutical industry
Websitehepionpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
423.28K
-
-
70.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
919.49K
527.90K
609.68K
728.51K
Operating expense
1.34M
527.90K
609.68K
798.51K
Total operating expenses
1.34M
527.90K
609.68K
798.51K
Operating income
-1.34M
-527.90K
-609.68K
-798.51K
Other non operating income
-
-
-
-10.15K
EBT including unusual items
-1.04M
-472.51K
-656.88K
-810.79K
EBT excluding unusual items
-1.34M
-519.79K
-622.26K
-810.79K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.04M
-472.51K
-656.88K
-810.79K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
4.87K
8.12K
-
-
Interest expense
-
-
-12.58K
-2.13K
Net interest expenses
4.87K
8.12K
-12.58K
-2.13K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.34M
-520.21K
-601.99K
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer